Category : Clinical Research, Pharma & Healthcare Financing

Clinical Research, Pharma & Healthcare Financing

Julius Clinical and Peachtree BioResearch Merge to Boost CNS CRO

PR Newswire
by PR Newswire0219
Julius Clinical, a leading full-service Contract Research Organization (CRO) headquartered in the Netherlands (Zeist), and Peachtree BioResearch Solutions, a specialized CNS CRO based in the United States (Georgia), announce...
Clinical Research, Pharma & Healthcare Financing

APHINITY Data: Perjeta Cuts Death Risk by 17% in HER2+ Breast Cancer

Business Wire
by Business Wire0211
– Long term follow-up in this curative setting demonstrated clinically meaningful survival benefit when adding adjuvant Perjeta® (pertuzumab) to Herceptin® (trastuzumab) and chemotherapy – – 21% reduction in...
Clinical Research, Pharma & Healthcare Financing

CARsgen Announces Positive Data for Allogeneic BCMA CAR-T CT0596

PR Newswire
by PR Newswire0201
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces preliminary clinical data for CT0596, an allogeneic BCMA-targeted...
Clinical Research, Pharma & Healthcare Financing

OmniAb Introduces the xPloration® Partner Access Program

Business Wire
by Business Wire0202
High-Throughput Single B-Cell Screening Platform Now Available for Purchase by OmniAb’s Partners for Use in Their Own Laboratories OmniAb, Inc. (NASDAQ: OABI) today introduced the launch...
Clinical Research, Pharma & Healthcare Financing

Sirius Therapeutics Raises $50M for siRNA Cardiometabolic Therapy

Business Wire
by Business Wire0236
Sirius Therapeutics today announced that it has successfully completed nearly $50 million Series B2 financing to advance clinical development of the Company’s novel siRNA therapeutics...
Clinical Research, Pharma & Healthcare Financing

Marengo Doses First Patient in STARt-002 Trial for Metastatic BC

PR Newswire
by PR Newswire0185
STARt-002 is a Phase 1b/2 clinical study assessing invikafusp alfa in combination with Gilead’s Trodelvy® for HR+/HER2- and TNBC breast cancer patients across leading U.S. and Canadian...